Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

New Tool Developed to Identify Genetic Risk Factors

By BiotechDaily International staff writers
Posted on 13 Feb 2014
Print article
Image: Pathway-based Human Phenotype Network classification shows relationships between diseases and traits based on shared etiology for certain phenotypes. The diseases and traits in these clusters have more connections to each other than to others in the network: the bolder the line, the stronger the connection (Photo courtesy of Dartmouth College).
Image: Pathway-based Human Phenotype Network classification shows relationships between diseases and traits based on shared etiology for certain phenotypes. The diseases and traits in these clusters have more connections to each other than to others in the network: the bolder the line, the stronger the connection (Photo courtesy of Dartmouth College).
A new biological pathway-based computational model has been developed to identify underlying genetic connections between different diseases.

The model called the Pathway-based Human Phenotype Network (PHPN) mines the data present in large publicly available disease datasets to find shared single nucleotide polymorphisms (SNPs), genes, or pathways and expresses them in a visual form.

Geneticists at the Geisel School of Medicine at Dartmouth (Hanover, NH, USA) built a pathway-based human phenotype network (PHPN) of over 800 physical attributes, diseases, and behavioral traits, based on about 2,300 genes and 1,200 biological pathways. Using genome-wide association study (GWAS) phenotype-to-genes associations, and pathway data from a free, open-source, curated and peer reviewed pathway database Reactome, they connected human traits based on the common patterns of human biological pathways, detecting more pleiotropic effects, and expanding previous studies from a gene-centric approach to that of shared cell-processes.

PHPN supports the integration of genomic and phenotypic data to uncover significant links between traits, attributes, and disease. This offers tremendous potential in identifying risk factors for certain diseases. At the same time, it can reveal important targets for therapeutic intervention. The automatic classification of phenotypes into “phenotype classes,” using the network’s topological modularity and a standard community detection algorithm, showed very promising results. Two traits that were connected in the PHPN but did not share any common associated genes or any clear-cut biological relationship were von Willebrand factor and FVIII levels (vWF) and hippocampal atrophy (HA).

Christian Darabos, PhD, the lead author of the study, said, “The intuitive network representation of the knowledge mined from several large-scale datasets makes the information accessible to anyone. It lies at the crossroads of computational genetics, systems biology, information theory, and network science. As a proof of concept, the PHPN has proven capable of identifying well-documented interactions, and many novel links that remain to be explored in depth. The PHPN is a hypothesis-generating tool, potentially capable of identifying yet uncharacterized common drug targets.” As a next step, the scientists will refine statistical methods, isolate networks for optimal results, and compare previous work on phenotype networks. The study was published on January 25, 2014, in the journal BioDataMining.

Related Links:

Geisel School of Medicine at Dartmouth
Reactome



Print article

Channels

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel
Image: A three-dimensional printer adapted for stem cell production (Photo courtesy of Nano Dimension).

Israeli Developers Demonstrate Prototype Three-Dimensional Bioprinter

Two Israeli companies have combined efforts in the development of three-dimensional printer technology for the production of stem cells. The three-dimensional print electronics developer Nano Dimension... Read more

Business

view channel

Acquisition to Boost Development of Drugs for Neurogenic Conditions

According to a recent announcement, a privately held biotechnology/drug development company is to be acquired by one of the major pharmaceutical manufacturers. The drug manufacturer Merck & Co. (Kenilworth, NJ, USA) has agreed to pay 500 million USD up front for Afferent Pharmaceuticals (San Mateo, CA, USA) and up... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.